Commentary: Potentially Inappropriate Medication Among Older Patients with Diabetic Kidney Disease
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Crescioli G, Boscia E, Bettiol A, Pagani S, Spada G, Vighi G
. Risk of Hospitalization for Adverse Drug Events in Women and Men: A Post Hoc Analysis of an Active Pharmacovigilance Study in Italian Emergency Departments. Pharmaceuticals (Basel). 2021; 14(7).
PMC: 8308702.
DOI: 10.3390/ph14070678.
View
2.
Wang Y, Ou-Yang Q, Huang W, Huang H, Zhuang X, Lin Q
. Investigation of the Inhibitory Effect of Simvastatin on the Metabolism of Lidocaine Both in vitro and in vivo. Drug Des Devel Ther. 2020; 14:1739-1747.
PMC: 7212776.
DOI: 10.2147/DDDT.S241022.
View
3.
Naseralallah L, Khatib M, Al-Khulaifi A, Danjuma M
. Prevalence and global trends of polypharmacy in patients with chronic kidney disease: A systematic review and meta-analysis. Front Pharmacol. 2023; 14:1122898.
PMC: 9950938.
DOI: 10.3389/fphar.2023.1122898.
View
4.
MacRae C, Mercer S, Guthrie B
. Potentially inappropriate primary care prescribing in people with chronic kidney disease: a cross-sectional analysis of a large population cohort. Br J Gen Pract. 2021; 71(708):e483-e490.
PMC: 8103925.
DOI: 10.3399/BJGP.2020.0871.
View
5.
. American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2019; 67(4):674-694.
DOI: 10.1111/jgs.15767.
View